Novartis Ceo Methods Down

Gan & Lee will shoulder manufacturing and improvement of the therapies, adhering to the manufacturing specifications for Sandoz biosimilars. As it moves toward streamlining its group structure, Novartis in 2019 spun off its Alcon eye care company and recently completed the sale of its almost a single-third...